TSXV - Delayed Quote
CAD
Vaxil Bio Ltd. (VXL.V)
0.1000
0.0000
(0.00%)
At close: October 28 at 3:23:39 PM EDT
Loading chart for VXL.V
- Previous Close
0.1000 - Open
0.1300 - Bid 0.1050 x --
- Ask 0.1450 x --
- Day's Range
0.1000 - 0.1300 - 52 Week Range
0.1000 - 0.2900 - Volume
14,888 - Avg. Volume
1,437 - Market Cap (intraday)
398,402 - Beta (5Y Monthly) -0.33
- PE Ratio (TTM)
0.67 - EPS (TTM)
0.1500 - Earnings Date (est.) Aug 27, 2026
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
VXL.V
31.03%
S&P/TSX Composite index (^GSPTSE)
11.78%
1-Year Return
VXL.V
47.37%
S&P/TSX Composite index (^GSPTSE)
18.03%
3-Year Return
VXL.V
900.00%
S&P/TSX Composite index (^GSPTSE)
88.90%
5-Year Return
VXL.V
11.11%
S&P/TSX Composite index (^GSPTSE)
69.32%
Statistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-16.59%
-
Return on Equity (ttm)
39.89%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
376k
-
Diluted EPS (ttm)
0.1500
Balance Sheet and Cash Flow
-
Total Cash (mrq)
464k
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
67.62k
